Bureau Veritas (1K) | Buy | Double re-rating in sight

Research evidence excerpt

Bureau Veritas (1K) | Buy | Double re-rating in sight

Bureau Veritas Buy | Target Price: EUR34.00

Slower start to the year than initially anticipated by the market

Bureau Veritas reported Q1 2026 organic revenue growth of +4.5%, with revenue of EUR1,547m,

down 0.8% reported year-on-year. The reported decline mainly reflected a -5.2% FX impact, while

scope was broadly neutral at -0.1%. This was below analyst consensus estimates, which expected

EUR1,557m of revenue and +5.1% organic growth, but slightly ahead of our estimate of +4.1%

organic growth.

Management presented the quarter as a softer point in the year, affected by demanding

comparables, project delays, and disruptions related to the Middle East. Nevertheless,

management stressed that several businesses performed in line with or above expectations and

that the portfolio continues to benefit from the execution of LEAP | 28.

The main new element was the downgrade to company guidance. Bureau Veritas now expects

mid-single-digit organic revenue growth in 2026, versus mid-to-high single-digit organic growth

previously. The company left its guidance unchanged for an improvement in adjusted operating

margin at constant exchange rates and strong cash flow generation.

The miss was moderate at the group level but more visible in the mix. Q1 organic growth came in

60bps below consensus, mainly due to weakness in Industry and Certification. By contrast, Marine

& Offshore, Buildings & Infrastructure, Consumer Products Services, and Agri-Food &

Commodities were broadly in line with or slightly ahead of expectations.

Our view is that the market reaction was excessive (-10.6% on 22 April, the day of the release). The

softer Q1 growth was largely expected, even if consensus had been overly optimistic. The negative